Company intelligence / Profile preview

Biocidin Botanicals

Aptos, California, United States

Ownership: Private
Employees: ~61
Development stage: Other

Overview

Biocidin Botanicals commercializes proprietary evidence-based botanical products targeting gut, systemic, and oral health through microbiome modulation. Their flagship product Biocidin® is widely used by functional and integrative health practitioners and has shown positive outcomes in clinical environments for over 30 years.[1][3][4][5]

Therapeutic areas: GastroenterologyOtherImmunology
Modalities: Botanical supplementNutraceuticalHerbal formulation
Industry: Food & Nutrition

Beyond the preview

Go deeper on Biocidin Botanicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biocidin Botanicals.

Explore the full profile